Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
Beam Therapeutics (NASDAQ:BEAM) is a gene editing company — one that gets less attention than its peers. Nonetheless, it currently has a...
Investing in Summit Materials (NYSE:SUM) five years ago would have delivered you a 195% gain
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money....
PDD Holdings Stock: Revenues Soar But Gross Margins Continue To Collapse (NASDAQ:PDD)
Back in May, I wrote that while PDD Holdings (NASDAQ:PDD) looked attractively valued, controversy surrounding the company kept me on the...
Christopher L. Washburn Sells 1,416 Shares of Pioneer Natural Resources (NYSE:PXD) Stock
Pioneer Natural Resources (NYSE:PXD – Get Free Report) CAO Christopher L. Washburn sold 1,416 shares of the stock in a transaction...
Hedge Funds Bet on Europe in Hunt for Next Leg of Stock Rally
Investors are betting that Europe will drive the next leg of the global equity rally, broadening their playbooks as a more expensive US market...
